• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.COVID-19 大流行期间炎症性肠病患者的实用管理：澳大利亚胃肠病学会炎症性肠病学院专家评论。
Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.
2
Management of inflammatory bowel diseases in the wake of COVID-19 pandemic.新冠疫情之后炎症性肠病的管理
J Gastroenterol Hepatol. 2020 Aug;35(8):1449-1450. doi: 10.1111/jgh.15056. Epub 2020 Apr 26.
3
Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.新冠疫情期间埃及的炎症性肠病
Inflamm Bowel Dis. 2020 Oct 23;26(11):1771-1778. doi: 10.1093/ibd/izaa195.
4
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.美国胃肠病学会关于2019冠状病毒病大流行期间炎症性肠病管理的临床实践更新：专家评论
Gastroenterology. 2020 Jul;159(1):350-357. doi: 10.1053/j.gastro.2020.04.012. Epub 2020 Apr 10.
5
The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China.新型冠状病毒肺炎大流行对中国炎症性肠病患者医疗模式的影响
Inflamm Bowel Dis. 2020 Sep 18;26(10):e116-e117. doi: 10.1093/ibd/izaa197.
6
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience.COVID-19 大流行时代的炎症性肠病护理：米兰 Humanitas 大学的经验。
J Crohns Colitis. 2020 Sep 16;14(9):1330-1333. doi: 10.1093/ecco-jcc/jjaa058.
7
COVID-19 Outbreak and Inflammatory Bowel Disease Management: A Questionnaire Survey From Realistic Practice.2019冠状病毒病疫情与炎症性肠病管理：一项来自实际临床的问卷调查
J Crohns Colitis. 2020 Oct 5;14(10):1494-1495. doi: 10.1093/ecco-jcc/jjaa064.
8
Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.S3指南增编：克罗恩病和溃疡性结肠炎——2019冠状病毒病大流行期间炎症性肠病患者的管理：开放式问答
Z Gastroenterol. 2020 Oct;58(10):982-1002. doi: 10.1055/a-1234-8079. Epub 2020 Oct 9.
9
Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic.新冠疫情期间中国炎症性肠病的治疗模式
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):632-634. doi: 10.1016/S2468-1253(20)30131-X. Epub 2020 May 13.
10
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?炎症性肠病医疗专业人员中的抗SARS-CoV-2抗体检测：我们目前能否提供无新冠病毒的炎症性肠病诊所？
Scand J Gastroenterol. 2020 Aug;55(8):917-919. doi: 10.1080/00365521.2020.1791244. Epub 2020 Jul 14.

引用本文的文献

1
Life changes, self-prevention, knowledge and mental health among inflammatory bowel disease patients during COVID-19 pandemic: a cross-sectional study.COVID-19 大流行期间炎症性肠病患者的生活变化、自我预防、知识和心理健康：一项横断面研究。
Front Public Health. 2024 Jun 12;12:1416880. doi: 10.3389/fpubh.2024.1416880. eCollection 2024.
2
Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management.炎症性肠病：临床诊断与药物治疗
Med Res Arch. 2023 Jan;11(1). doi: 10.18103/mra.v11i1.3135. Epub 2023 Jan 31.
3
Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.炎症性肠病：临床诊断与外科治疗概述。
Medicina (Kaunas). 2022 Apr 21;58(5):567. doi: 10.3390/medicina58050567.
4
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.临床实践新进展：COVID-19 大流行期间炎症性肠病的管理。
Gut. 2022 Jul;71(7):1426-1439. doi: 10.1136/gutjnl-2021-326784. Epub 2022 Apr 27.
5
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.跨膜丝氨酸蛋白酶 2 和血管紧张素转换酶 2 抗炎受体治疗 COVID-19/炎症性肠病。
World J Gastroenterol. 2021 Dec 14;27(46):7943-7955. doi: 10.3748/wjg.v27.i46.7943.
6
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements.韩国肠道疾病研究协会关于2019冠状病毒病大流行期间成人炎症性肠病临床实践的指南：专家共识声明
Intest Res. 2022 Oct;20(4):431-444. doi: 10.5217/ir.2021.00111. Epub 2022 Jan 5.
7
COVID-19: looking backward.新冠疫情：回顾往昔。
Intern Med J. 2021 Aug;51(8):1203-1204. doi: 10.1111/imj.15461.
8
A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.机器学习方法表明，5-氨基水杨酸和溃疡性结肠炎与 IBD 患者 COVID-19 死亡率升高相关。
Sci Rep. 2021 Aug 13;11(1):16522. doi: 10.1038/s41598-021-95919-2.
9
Management of inflammatory bowel disease in the COVID-19 era.新冠疫情时代炎症性肠病的管理
Intest Res. 2022 Jan;20(1):3-10. doi: 10.5217/ir.2020.00156. Epub 2021 Feb 3.
10
Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.新型冠状病毒感染患者的胃肠道和肾脏并发症：免疫系统的作用。
Scand J Immunol. 2021 Apr;93(4):e12999. doi: 10.1111/sji.12999. Epub 2020 Dec 7.

本文引用的文献

1
First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community.澳大利亚首批未经处理污水中 SARS-CoV-2 的检测确认：社区新冠病毒污水监测的概念验证。
Sci Total Environ. 2020 Aug 1;728:138764. doi: 10.1016/j.scitotenv.2020.138764. Epub 2020 Apr 18.
2
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.综述文章：炎症性肠病患者 COVID-19 的预防、诊断和管理。
Aliment Pharmacol Ther. 2020 Jul;52(1):54-72. doi: 10.1111/apt.15779. Epub 2020 May 26.
3
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.在一家专业护理机构中出现的 SARS-CoV-2 感染前驱期和传播。
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
4
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.英国胃肠病学会在 COVID-19 大流行期间炎症性肠病管理指南。
Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020-321244. Epub 2020 Apr 17.
5
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征：一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
6
Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.2019冠状病毒病大流行期间克罗恩病和溃疡性结肠炎患者的管理：一次国际会议的结果
Gastroenterology. 2020 Jul;159(1):6-13.e6. doi: 10.1053/j.gastro.2020.04.002. Epub 2020 Apr 6.
7
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章：COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
8
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
9
Evidence for Gastrointestinal Infection of SARS-CoV-2.新型冠状病毒2019（SARS-CoV-2）胃肠道感染的证据。
Gastroenterology. 2020 May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055. Epub 2020 Mar 3.
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.

COVID-19 大流行期间炎症性肠病患者的实用管理：澳大利亚胃肠病学会炎症性肠病学院专家评论。

Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.

机构信息

Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Victorian Infectious Diseases Unit, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

出版信息

Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.

DOI:10.1111/imj.14889
PMID:32656985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7405147/
Abstract

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting.

摘要

由新型冠状病毒 SARS-CoV-2 引起的 COVID-19 大流行已经成为一项公共卫生紧急事件，对全球的医疗保健系统构成了挑战。在少数患者中，SARS-CoV-2 表现为严重急性呼吸道疾病，目前关于接受免疫抑制治疗的炎症性肠病患者 COVID-19 的毒力的数据还不足够。这篇综述旨在总结目前的文献，并就澳大利亚背景下 COVID-19 大流行期间炎症性肠病患者的管理提供指导。